Rafael Holdings

Holding Companies & Conglomerates · New Jersey, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

520 Broad St, Newark, New Jersey, 07102,...

Phone Number

(212) 658-1450

Revenue

<$5 Million

Stock Symbol

RFL

Industry

Holding Companies & Conglomerates
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
2
2
3
3
2

About Rafael Holdings

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages inRead more
Rafael Holdings's Social MediaPopular SearchesRafael Holdings IncRafael HoldingsRafael Holdings LLCBarer InstituteSIC Code 67,671NAICS Code 55,551Ticker NYSE: RFLShow more

Rafael Holdings Org Chart

PhoneEmail
Joshua Fine, Chief Operating Officer at Rafael Holdings
United States flag for contact location.

Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
NY
United States flag for contact location.

Manager, Production

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Rafael Holdings your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Rafael Holdings

Compare insights from companies similar to Rafael Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Rafael Holdings

<$5M
11-50
Public
<$5M
2019
Joshua Fine, Chief Operating Officer at Rafael Holdings
Joshua FineChief Operating Officer
$9M
11-50
Public
$600.5M
2014
Paula Ragan, Founder, President & Chief Executive Officer at X4 Pharmaceuticals
Paula RaganFounder, President & CEO
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Public
$429.2M
2004
JL
Jenny LamportVice President, Regulatory
<$5M
1-10
Public
-
1982
MC
Michael CatelaniPresident & Chief Operating Officer & Chief Financial Officer
<$5M
11-50
Public
-
2000
HW
Howard WachtlerPresident & CEO
1-10
Public
$12.1M
1965
Alan Urban, Chief Financial Officer at GT Biopharma
Alan UrbanChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Holding Companies & Conglomerates companies

Low Activity

High Activity

Activity Insights

Rafael Holdings is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.

What does this means?

Rafael Holdings is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Rafael Holdings.

Rafael Holdings financials insights

Gather financial insights about Rafael Holdings, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2020

Debt

$350K

See All Rafael Holdings's Financials Insights

Rafael Holdings Tech Stack

A closer look at the technologies used by Rafael Holdings

Most Recent Scoops

Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Lateral Move
Executive Move
Executive Moves, Lateral Move
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
See more scoops

Top Holding Companies & Conglomerates Companies

Frequently Asked Questions Regarding Rafael Holdings

What is Rafael Holdings's stock symbol?
Rafael Holdings's stock symbol is RFL
What is Rafael Holdings's official website?
Rafael Holdings's official website is www.rafaelholdings.com
What is Rafael Holdings's Revenue?
Rafael Holdings's revenue is <$5 Million
What is Rafael Holdings's SIC code?
Rafael Holdings's SIC: 67,671
What is Rafael Holdings's NAICS code?
Rafael Holdings's NAICS: 55,551
How many employees does Rafael Holdings have?
Rafael Holdings has 11-50 employees
What industry does Rafael Holdings belong to?
Rafael Holdings is in the industry of: Holding Companies & Conglomerates
What is Rafael Holdings competition?
Rafael Holdings top competitors include: Advanced Cancer Research, X4 Pharmaceuticals, Bellicum, Actinium Pharmaceuticals
What companies has Rafael Holdings acquired?
Rafael Holdings has acquired the companies: Cyclo Therapeutics, Applied Molecular Transport
What technology does Rafael Holdings use?
Some of the popular technologies that Rafael Holdings uses are: WordPress.org, PHP, Google Font API, TriNet
How do I contact Rafael Holdings?
Rafael Holdings contact info: Phone number: (212) 658-1450 Website: www.rafaelholdings.com
What does Rafael Holdings do?

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic difference... s between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More

What are Rafael Holdings social media links?
Rafael Holdings Linkedin page Rafael Holdings Twitter page
Is Rafael Holdings a public company?
Yes, Rafael Holdings is a public company and is traded under the symbol RFL
See more information about Rafael Holdings

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.